O

OVID

Ovid Therapeutics Inc

0.35

0.00+0.89%
After Hours: 0.3698  +0.0198  +5.66%19:25 04/28 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

92.17M

144.03M

155.27M

194.54M

75.93M

Total Current Assets

55.94M

109.60M

131.38M

190.48M

74.84M

Total Non Current Assets

36.23M

34.43M

23.89M

4.07M

1.08M

Total Liabilities

23.94M

56.23M

22.99M

14.80M

32.29M

Total Current Liabilities

10.52M

11.47M

6.99M

14.80M

22.06M

Total Non Current Liabilities

13.42M

44.76M

16.00M

0

10.23M

Total Equity

68.23M

87.80M

132.27M

179.75M

43.63M

Total Stockholders Equity

68.23M

87.80M

132.27M

179.75M

43.63M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

92.17M

144.03M

155.27M

194.54M

75.93M

Total Common Shares Outstanding

71.01M

70.69M

70.47M

70.36M

65.74M

Total Preferred Shares Outstanding

1.25K

1.25K

1.25K

1.25K

3.25K